Sales Surge and Reinsurance Deal: Strong Capital and Growth Secured (AFL Q1 2026 Earnings Call)

By Dr. Graph | Updated on May 26, 2026 | earnings

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Aflac Incorporated commenced the fiscal year with solid financial results, achieving reported net earnings per diluted share of $1.98 and adjusted earnings per diluted share of $1.75. Backed by robust capital generation, the company returned a total of $1.3 billion to its shareholders during the first quarter through a combination of share repurchases and dividends.

Operational Performance Lifts Currency-Adjusted Earnings

Aflac Incorporated achieved a strong currency-adjusted operational performance in the first quarter of the fiscal year. CFO Max Broden reported that adjusted earnings per diluted share increased by 6.6% year-over-year when excluding foreign currency effects, reaching $1.77. This operational momentum translated into a solid adjusted return on equity of 12.8%, showcasing the company's core profitability and high return on capital.

Stable Benefit Ratios and Robust Liquidity Anchor Outlook

Management maintains high confidence in its long-term financial trajectory, supported by a stable and well-monitored capital position. Max Broden noted, "We still feel very confident with the outlook range that we gave at the beginning of the year of 60% to 63% for the Japan benefit ratio." Additionally, the company maintained excellent holding company liquidity, ending the quarter with unencumbered liquid assets of $3.4 billion, which ensures superior financial flexibility.

Innovative Offerings and Voluntary Group Products Boost Dual-Segment Sales

Strong customer demand for new products drove significant sales momentum across both primary operating segments. In Aflac Japan, first-quarter sales surged by 25.5% as consumers responded enthusiastically to the newly introduced Onsen Tallett medical product and the Miraito cancer insurance policy. Concurrently, Aflac U.S. expanded its net earned premiums by 3.5% through disciplined underwriting, aided by a 12.4% increase in group product sales.

Strategic Reinsurance Expansion and Agent Optimization Drive Operational Discussions

During the analyst Q&A session, management elaborated on capital optimization initiatives and channel expansion strategies. Max Broden discussed the reinsurance transaction executed by Aflac Re Bermuda, noting that while the assumed block of whole life annuities is currently immaterial, it represents a key platform for long-term growth. Furthermore, Virgil Miller explained that while the traditional agent channel remains flat, new agent success metrics improved by 8% due to onboarding enhancements, while group life and absence disability sales rose by 25%.

Frequently Asked Questions

What was Aflac Japan's reported benefit ratio and persistency during the first quarter?

Aflac Japan's total benefit ratio came in at 62.9%, representing a decline of 290 basis points year-over-year. Persistency remained strong and in line with expectations at 92.8%.

What was the capital adequacy position of Aflac Incorporated at the end of the quarter?

The company ended the quarter with an estimated regulatory capital adequacy ratio (ESR) of 227%. Incorporating the undertaking specific parameter increases the ESR to 243%.

How did reserve remeasurement gains impact Aflac U.S. results?

Reserve remeasurement gains reduced benefits and impacted the Aflac U.S. benefit ratio by approximately 230 basis points, which was 80 basis points above the company's plan.

What is Aflac U.S.'s new agent recruitment success?

During the first quarter, Aflac U.S. achieved a new agent conversion rate of 16%.